1. Home
  2. NRSN vs SURG Comparison

NRSN vs SURG Comparison

Compare NRSN & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • SURG
  • Stock Information
  • Founded
  • NRSN 2017
  • SURG 2006
  • Country
  • NRSN Israel
  • SURG United States
  • Employees
  • NRSN N/A
  • SURG N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • SURG Advertising
  • Sector
  • NRSN Health Care
  • SURG Consumer Discretionary
  • Exchange
  • NRSN Nasdaq
  • SURG Nasdaq
  • Market Cap
  • NRSN 26.0M
  • SURG 27.0M
  • IPO Year
  • NRSN 2021
  • SURG N/A
  • Fundamental
  • Price
  • NRSN $0.91
  • SURG $2.25
  • Analyst Decision
  • NRSN Hold
  • SURG Strong Buy
  • Analyst Count
  • NRSN 1
  • SURG 1
  • Target Price
  • NRSN N/A
  • SURG $8.50
  • AVG Volume (30 Days)
  • NRSN 172.3K
  • SURG 4.5M
  • Earning Date
  • NRSN 04-08-2025
  • SURG 03-25-2025
  • Dividend Yield
  • NRSN N/A
  • SURG N/A
  • EPS Growth
  • NRSN N/A
  • SURG N/A
  • EPS
  • NRSN N/A
  • SURG N/A
  • Revenue
  • NRSN N/A
  • SURG $60,881,173.00
  • Revenue This Year
  • NRSN N/A
  • SURG $59.22
  • Revenue Next Year
  • NRSN N/A
  • SURG $75.86
  • P/E Ratio
  • NRSN N/A
  • SURG N/A
  • Revenue Growth
  • NRSN N/A
  • SURG N/A
  • 52 Week Low
  • NRSN $0.51
  • SURG $1.05
  • 52 Week High
  • NRSN $2.25
  • SURG $4.38
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 29.02
  • SURG 63.22
  • Support Level
  • NRSN $1.00
  • SURG $1.70
  • Resistance Level
  • NRSN $1.13
  • SURG $2.50
  • Average True Range (ATR)
  • NRSN 0.08
  • SURG 0.25
  • MACD
  • NRSN -0.02
  • SURG 0.09
  • Stochastic Oscillator
  • NRSN 8.23
  • SURG 50.81

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.

Share on Social Networks: